CN107365680A - 一种利用名酒大曲制备的食醋/醋膏及其应用 - Google Patents
一种利用名酒大曲制备的食醋/醋膏及其应用 Download PDFInfo
- Publication number
- CN107365680A CN107365680A CN201710603301.7A CN201710603301A CN107365680A CN 107365680 A CN107365680 A CN 107365680A CN 201710603301 A CN201710603301 A CN 201710603301A CN 107365680 A CN107365680 A CN 107365680A
- Authority
- CN
- China
- Prior art keywords
- vinegar
- raw material
- daqu
- cream
- famous brand
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000052 vinegar Substances 0.000 title claims abstract description 206
- 235000021419 vinegar Nutrition 0.000 title claims abstract description 206
- 239000006071 cream Substances 0.000 title claims abstract description 91
- 235000014101 wine Nutrition 0.000 title claims abstract description 45
- 239000003814 drug Substances 0.000 claims abstract description 26
- 210000004185 liver Anatomy 0.000 claims abstract description 23
- 230000036541 health Effects 0.000 claims abstract description 20
- 239000004475 Arginine Substances 0.000 claims abstract description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims abstract description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims abstract description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229940024606 amino acid Drugs 0.000 claims abstract description 3
- 150000001413 amino acids Chemical class 0.000 claims abstract description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229940009098 aspartate Drugs 0.000 claims abstract description 3
- 239000004474 valine Substances 0.000 claims abstract description 3
- 239000007788 liquid Substances 0.000 claims description 56
- 239000002994 raw material Substances 0.000 claims description 51
- 210000002966 serum Anatomy 0.000 claims description 45
- 235000013339 cereals Nutrition 0.000 claims description 21
- 238000000855 fermentation Methods 0.000 claims description 21
- 230000004151 fermentation Effects 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 15
- 240000006394 Sorghum bicolor Species 0.000 claims description 11
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 11
- 241000209140 Triticum Species 0.000 claims description 11
- 235000021307 Triticum Nutrition 0.000 claims description 11
- 230000032683 aging Effects 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 11
- 230000009467 reduction Effects 0.000 claims description 11
- 244000062793 Sorghum vulgare Species 0.000 claims description 9
- 108090000340 Transaminases Proteins 0.000 claims description 9
- 235000019713 millet Nutrition 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 240000007594 Oryza sativa Species 0.000 claims description 8
- 235000007164 Oryza sativa Nutrition 0.000 claims description 8
- 235000009566 rice Nutrition 0.000 claims description 8
- 240000005979 Hordeum vulgare Species 0.000 claims description 7
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 7
- 240000004713 Pisum sativum Species 0.000 claims description 7
- 244000005700 microbiome Species 0.000 claims description 7
- 235000015096 spirit Nutrition 0.000 claims description 7
- 238000010025 steaming Methods 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 235000012000 cholesterol Nutrition 0.000 claims description 5
- 238000002386 leaching Methods 0.000 claims description 5
- 235000020068 maotai Nutrition 0.000 claims description 4
- 235000010582 Pisum sativum Nutrition 0.000 claims description 3
- 239000013590 bulk material Substances 0.000 claims description 3
- 235000009508 confectionery Nutrition 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 230000008595 infiltration Effects 0.000 claims description 2
- 238000001764 infiltration Methods 0.000 claims description 2
- 210000002700 urine Anatomy 0.000 claims description 2
- 102000003929 Transaminases Human genes 0.000 claims 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 abstract description 11
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 abstract description 11
- 229940116269 uric acid Drugs 0.000 abstract description 11
- 238000000034 method Methods 0.000 abstract description 10
- 150000003626 triacylglycerols Chemical class 0.000 abstract description 10
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 abstract description 2
- 108010082126 Alanine transaminase Proteins 0.000 abstract description 2
- 241000699670 Mus sp. Species 0.000 description 23
- 239000013641 positive control Substances 0.000 description 13
- 102000007330 LDL Lipoproteins Human genes 0.000 description 11
- 108010007622 LDL Lipoproteins Proteins 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 108010010234 HDL Lipoproteins Proteins 0.000 description 8
- 102000015779 HDL Lipoproteins Human genes 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 230000008859 change Effects 0.000 description 7
- 208000010706 fatty liver disease Diseases 0.000 description 7
- 239000007901 soft capsule Substances 0.000 description 7
- 102000014898 transaminase activity proteins Human genes 0.000 description 7
- 208000004930 Fatty Liver Diseases 0.000 description 6
- 206010019708 Hepatic steatosis Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000003304 gavage Methods 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 210000005229 liver cell Anatomy 0.000 description 6
- 208000019423 liver disease Diseases 0.000 description 6
- 231100000240 steatosis hepatitis Toxicity 0.000 description 6
- 241000282414 Homo sapiens Species 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 3
- 229960004245 silymarin Drugs 0.000 description 3
- 235000017700 silymarin Nutrition 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N carbon tetrachloride Substances ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 206010053219 non-alcoholic steatohepatitis Diseases 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 235000020097 white wine Nutrition 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- 208000008964 Chemical and Drug Induced Liver Injury Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 208000027761 Hepatic autoimmune disease Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 230000001553 hepatotropic effect Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000013190 lipid storage Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 208000009928 nephrosis Diseases 0.000 description 1
- 231100001027 nephrosis Toxicity 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000003182 parenteral nutrition solution Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 208000018655 severe necrosis Diseases 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000012859 sterile filling Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12J—VINEGAR; PREPARATION OR PURIFICATION THEREOF
- C12J1/00—Vinegar; Preparation or purification thereof
- C12J1/04—Vinegar; Preparation or purification thereof from alcohol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/17—Preparation or pretreatment of starting material involving drying, e.g. sun-drying or wilting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
组别 | 剂量(g/kg•d) | n | 肝指数(%) | 脾指数(%) |
正常组 | 0 | 6 | 5.270.04 | 0.370.01 |
模型组 | 0 | 6 | 8.740.66## | 0.750.19## |
醋膏口服液组 | 2 | 6 | 7.730.23##* | 0.700.09##* |
市售醋液组 | 4 | 6 | 8.091.33## | 0.750.27## |
阳性对照组 | 0.1 | 6 | 6.580.94##* | 0.630.16##** |
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710603301.7A CN107365680A (zh) | 2017-07-22 | 2017-07-22 | 一种利用名酒大曲制备的食醋/醋膏及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710603301.7A CN107365680A (zh) | 2017-07-22 | 2017-07-22 | 一种利用名酒大曲制备的食醋/醋膏及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107365680A true CN107365680A (zh) | 2017-11-21 |
Family
ID=60307331
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710603301.7A Pending CN107365680A (zh) | 2017-07-22 | 2017-07-22 | 一种利用名酒大曲制备的食醋/醋膏及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107365680A (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110862900A (zh) * | 2018-08-27 | 2020-03-06 | 张家界大德酿造有限公司 | 一种果蔬发酵液的制备方法及其应用 |
CN110859894A (zh) * | 2018-08-27 | 2020-03-06 | 张家界大德酿造有限公司 | 一种基于名酒大曲微生物菌群制备发酵药物的方法及发酵药物 |
CN111346080A (zh) * | 2018-12-21 | 2020-06-30 | 张家界大德酿造有限公司 | 一种九曲香酯醋制剂在制备治疗痛风药物中的应用 |
CN111700913A (zh) * | 2019-03-18 | 2020-09-25 | 石小和 | 药醋、美洲大蠊组合物及其制备方法和应用 |
CN111714520A (zh) * | 2019-03-18 | 2020-09-29 | 石小和 | 美洲大蠊制剂及其制备方法和应用 |
CN112076312A (zh) * | 2019-06-13 | 2020-12-15 | 石小和 | 具有免疫调节作用的疫苗、多抗血清注射剂及制备方法 |
CN112094724A (zh) * | 2019-06-17 | 2020-12-18 | 石小和 | 一种食醋及其制备方法和应用 |
US11584904B2 (en) * | 2019-05-23 | 2023-02-21 | Crush Dynamics Inc. | System, method, process and nutrient-rich product derived from wine derivatives |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005176776A (ja) * | 2003-12-22 | 2005-07-07 | Ogatamura Akitakomachi Seisansha Kyokai:Kk | 米の研ぎ汁を用いた食酢及び清涼飲料水の製造方法 |
CN101109004A (zh) * | 2006-07-17 | 2008-01-23 | 北京大德水景科技有限公司 | 利用名酒菌系大曲制备食醋的方法 |
CN103451084A (zh) * | 2013-09-05 | 2013-12-18 | 何志锋 | 一种解酒保肝醋及其制备方法与应用 |
-
2017
- 2017-07-22 CN CN201710603301.7A patent/CN107365680A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005176776A (ja) * | 2003-12-22 | 2005-07-07 | Ogatamura Akitakomachi Seisansha Kyokai:Kk | 米の研ぎ汁を用いた食酢及び清涼飲料水の製造方法 |
CN101109004A (zh) * | 2006-07-17 | 2008-01-23 | 北京大德水景科技有限公司 | 利用名酒菌系大曲制备食醋的方法 |
CN103451084A (zh) * | 2013-09-05 | 2013-12-18 | 何志锋 | 一种解酒保肝醋及其制备方法与应用 |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110862900A (zh) * | 2018-08-27 | 2020-03-06 | 张家界大德酿造有限公司 | 一种果蔬发酵液的制备方法及其应用 |
CN110859894A (zh) * | 2018-08-27 | 2020-03-06 | 张家界大德酿造有限公司 | 一种基于名酒大曲微生物菌群制备发酵药物的方法及发酵药物 |
CN111346080A (zh) * | 2018-12-21 | 2020-06-30 | 张家界大德酿造有限公司 | 一种九曲香酯醋制剂在制备治疗痛风药物中的应用 |
CN111700913A (zh) * | 2019-03-18 | 2020-09-25 | 石小和 | 药醋、美洲大蠊组合物及其制备方法和应用 |
CN111714520A (zh) * | 2019-03-18 | 2020-09-29 | 石小和 | 美洲大蠊制剂及其制备方法和应用 |
US11584904B2 (en) * | 2019-05-23 | 2023-02-21 | Crush Dynamics Inc. | System, method, process and nutrient-rich product derived from wine derivatives |
CN112076312A (zh) * | 2019-06-13 | 2020-12-15 | 石小和 | 具有免疫调节作用的疫苗、多抗血清注射剂及制备方法 |
CN112094724A (zh) * | 2019-06-17 | 2020-12-18 | 石小和 | 一种食醋及其制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107365680A (zh) | 一种利用名酒大曲制备的食醋/醋膏及其应用 | |
KR101809172B1 (ko) | 뮤신이 없는 배지에서 배양한 아커만시아 뮤시니필라 균주 또는 이의 배양액을 유효성분으로 함유하는 대사성 질환의 예방, 개선 또는 치료용 조성물 | |
EP1902722B1 (en) | Agent for elevating adiponectin concentration | |
JP6684966B2 (ja) | 新規なラクトバチルス・サケイ及びそれを含む組成物 | |
EP2097082A1 (en) | Pharmaceutical composition comprising metadoxine and garlic oil for preventing and treating alcohol-induced fatty liver and steatohepatitis | |
CN107981324A (zh) | 姜黄发酵食品及其制备方法 | |
WO2020177389A1 (zh) | 一种含麦角硫因的猴头菌保健品制剂及其制备方法 | |
KR20110041050A (ko) | 발효차 추출물을 함유하는 혈액 순환 개선 및 수족 냉증 개선용 조성물 | |
CN104232441A (zh) | 一种健康保健养生虫草酒及其制备方法 | |
KR20150055876A (ko) | 체지방 감소 또는 체중 감소를 위한 조성물 | |
JP6066919B2 (ja) | 発酵茶抽出物を含む脂質水準減少用組成物 | |
CN101664180A (zh) | 一种具有保健功效的营养复合剂及其制备方法 | |
CN104055947B (zh) | 一种含有葡萄提取物的中药组合物及制备方法 | |
CN101057674B (zh) | 一种用于防治糖尿病的组合物 | |
KR20160141027A (ko) | 아위버섯 물 추출물을 유효성분으로 함유하는 대사성질환의 예방 및 치료용 약학적 조성물 또는 건강기능성식품 | |
CN106924548A (zh) | 一种缓解疲劳的药物及制备方法 | |
CN111357982A (zh) | 沙棘复合发酵液及其制备方法、保健饮品、植物酵素 | |
JP2005213211A (ja) | 血糖値上昇抑制剤 | |
CN105558244A (zh) | 一种辅助降血脂降血糖并提高免疫力的食品及其制备方法 | |
CN110074392A (zh) | 一种解酒保肝养胃护肠组合物及其制备方法 | |
CN110384240A (zh) | 降血糖的维生素和益生菌发酵物粉营养组合物及其应用 | |
CN109045070A (zh) | 一种防治非酒精性脂肪肝病的组合物 | |
CN107136499A (zh) | 用于肿瘤病人术后增强免疫力的复方制剂 | |
KR101336068B1 (ko) | 한약재의 추출물과 분획물을 포함하는 항당뇨 조성물 | |
CN108159201A (zh) | 一种调节高脂人群肠道菌群的产品及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180611 Address after: 427000 Hunan province Zhangjiajie Yongding District Cili County Yan Po Du neighborhood committee Applicant after: Zhangjiajie Dade biotechnology limited liability company Address before: 427000 Yan Po Du neighborhood committee, Yan Po Du Town, Cili, Zhangjiajie, Hunan Applicant before: Zhangjiajie Dade biotechnology limited liability company Applicant before: Jiangnan University |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171121 |